Cinacalcet Improves Bone Density in Post–Kidney Transplant Hyperparathyroidism
Authors:
- M.E. ChoMCM.E. Cho
- M.S. RingMRM.S. Ring
- 1 November 2010
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 42 (9) , 3554-3558
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 9 references indexed in Scilit:
- Calcimimetics and Bone Mineral Density in Renal Transplant Patients With Persistent Secondary HyperparathyroidismTransplantation Proceedings, 2009
- Treatment of Persistent Hyperparathyroidism in Renal Transplant Patients With Cinacalcet Improves Control of Blood PressureTransplantation Proceedings, 2009
- Evolution of Secondary Hyperparathyroidism After Kidney Transplantation in Patients Receiving Cinacalcet on DialysisTransplantation Proceedings, 2009
- Treatment With Cinacalcet in 29 Kidney Transplant Patients With Persistent HyperparathyroidismTransplantation Proceedings, 2009
- Effect of Cinacalcet on Hypercalcemia and Bone Mineral Density in Renal Transplanted Patients With Secondary HyperparathyroidismTransplantation, 2008
- Cinacalcet improves bone mineral density in a renal transplant recipient with persistent hyperparathyroidism.Clinical Nephrology, 2008
- Cinacalcet for the Treatment of Hypercalcemia in Renal Transplanted Patients With Secondary HyperparathyroidismTransplantation Proceedings, 2007
- Elevated calcium phosphate product after renal transplantation is a risk factor for graft failureClinical Transplantation, 2007
- POSTTRANSPLANT BONE DISEASE: EVIDENCE FOR A HIGH BONE RESORPTION STATETransplantation, 2000